Midatech Pharma PLC
LSE:MTPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nousouken Corp
TSE:3541
|
JP |
|
Asahi Songwon Colors Ltd
BSE:532853
|
IN |
|
S
|
SMC Trading Investment JSC
VN:SMC
|
VN |
|
Renault SA
PAR:RNO
|
FR |
|
A
|
Ascent Solar Technologies Inc
NASDAQ:ASTI
|
US |
|
Zhongliang Holdings Group Company Ltd
HKEX:2772
|
CN |
|
LS Electric Co Ltd
KRX:010120
|
KR |
|
BYGGFAKTA GROUP Nordic HoldCo AB
STO:BFG
|
SE |
|
O
|
Opal Balance Investments Ltd
TASE:OPAL
|
IL |
|
Synlait Milk Ltd
NZX:SML
|
NZ |
|
Doosan Bobcat Inc
KRX:241560
|
KR |
Midatech Pharma PLC
Other
Midatech Pharma PLC
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Midatech Pharma PLC
LSE:MTPH
|
Other
-£15k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Other
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Compass Pathways PLC
NASDAQ:CMPS
|
Other
$1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Other
-£5.7m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-30%
|
|
|
Oxford BioMedica PLC
LSE:OXB
|
Other
-£14.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Midatech Pharma PLC
Glance View
Midatech Pharma Plc is a drug delivery technology company. The company is headquartered in Abingdon, Oxfordshire and currently employs 40 full-time employees. The company went IPO on 2014-12-08. The firm has developed three in-house technology platforms, each with its own mechanism to improve delivery of medications to sites of disease. The firm's platform includes Q-Sphera platform, MidaSolve platform and MidaCore platform. Q-Sphera platform is a micro-technology used for sustained release to prolong and control the release of therapeutics over an extended period of time (from weeks to months). MidaSolve platform is a nanotechnology used to dissolve insoluble drugs, which can be administered in liquid form directly and locally into tumors. MidaCore platform is a nanotechnology used for targeting medications to sites of disease. The company has a pipeline of approximately 10 earlier stage programmes, which includes MTD211, MTD214, MTD220, MTX213, MTX214, MTX216, MTX110, MTX110, MTX110 and MTX114.
See Also
What is Midatech Pharma PLC's Other?
Other
-15k
GBP
Based on the financial report for Dec 31, 2021, Midatech Pharma PLC's Other amounts to -15k GBP.
